Oruka Therapeutics General Counsel Paul Quinlan reports sale of 9,000 common shares for $853,985.65
ORKA•Oruka Therapeutics General Counsel Paul T. Quinlan sold 9,000 common shares on Nov. 20, 2026, for $853,985.65 and exercised employee warrants to acquire 9,000 shares at $7.80 each.




